Botulinum Toxin for Primary Disorders of Mood and Affect using Neurotransmitter CNS imaging Studies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160095908A1
SERIAL NO

14966759

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides methods for treating primary disorders of mood and affect, including depressive disorders, anxiety, and sleep disorders and CNS disorders comprising the administration of a neurotoxin.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
REVANCE THERAPEUTICS INC7555 GATEWAY BOULEVARD NEWARK CA 94560

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Acquadro, Martin Wellesley, US 7 17
Borodic, Gary E Quincy, US 53 723

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation